Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Clinical trial NCT00305942 · COMPLETED

Trial details

NCT number: NCT00305942
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Small Cell

Start date: 2006-03-01
Primary completion: 2009-04-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.